Key facts
- Orca Capital AG filed SCHEDULE 13G for Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT).
- Disclosed ownership: 8.1%.
- Date of event: 11 Feb 2025.
Orca Capital AG - 11 Feb 2025 SCHEDULE 13G Report for Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- LIXT
- Shares outstanding
- 2,683,852 shares
- Disclosed Ownership
- 217,392 shares
- Ownership
- 8.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2025, 16:48:30 UTC
- Date of event
- 11 Feb 2025
- Next filing
- 18 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Orca Capital AG disclosed 8.1% ownership in Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT) on 11 Feb 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 16:48.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 8.1% | 217,392 | 217,392 | 0 | /s/ Thomas Konig | Thomas Konig/Director |
CIK / CUSIP context first